generics

Pharma Starts a Feedback Loop
Drug Patent Watch
Mon, 06/12/17 - 10:08 am
patents
generics
patent expirations
patent cliffs
innovation
drug development
Lilly's Strattera faces first wave of generic competition
BioPharma Dive
Fri, 06/2/17 - 11:31 am
Eli Lilly
Strattera
generics
ADHD
Apotex
Aurobindo
Glenmark
Teva Pharmaceutical
Instant Analysis: Mallinckrodt Considering Sale of Generics Unit
Motley Fool
Thu, 06/1/17 - 08:48 am
Mallinckrodt
generics
M&A
Another old, cheap generic is being prepped for an FDA application — made over into a ‘new’ drug for ADHD and narcolepsy
Endpoints
Wed, 05/31/17 - 09:25 am
generics
FDA
NLS Pharma
ADHD
narcolepsy
Mazindol
[video]FDA to publish list of drugs with no generic competitor
Yahoo/CNBC
Mon, 05/29/17 - 11:57 am
FDA
generics
competition
Sanofi Wins False Claims Case Appealed by Rival Drugmaker
Bloomberg
Thu, 05/18/17 - 09:54 pm
Sanofi
False Claims Act
Amphastar
generics
patents
The top 15 generic drugmakers by 2016 revenue
Fierce Pharma
Wed, 05/17/17 - 09:39 am
generics
Teva Pharmaceutical
Mylan Labs
Novartis
Pfizer
Allergan
Novartis pushes further into pain with Durect deal
BioPharma Dive
Tue, 05/9/17 - 10:45 pm
Novartis
Durect
Sandoz
biosimilars
generics
Posimir
R&D
FDA’s Ruling on Generic ZITHROMAX 180-Day Exclusivity: A Little Something for Everyone!
FDA Law Blog
Mon, 05/8/17 - 11:32 am
FDA
generics
Zithromax
exclusivity
Pfizer
Lupin
antibiotics
Merck's Vytorin set for massive sales slide as generics hit
Fierce Pharma
Sun, 04/30/17 - 12:53 pm
Merck
Vytorin
generics
Teva Pharmaceutical
Impax Labs
FDA approves Impax generic of Merck's cholesterol drug Vytorin
Yahoo/Reuters
Wed, 04/26/17 - 09:36 pm
FDA
Impax Labs
generics
Merck
Vytorin
Fresenius Kabi picks up generic maker Akorn for $4.3B
BioPharma Dive
Tue, 04/25/17 - 11:22 am
M&A
generics
Fresenius
Akorn
Novartis' Gilenya patent loss sets MS market up for battle with early generics
Fierce Pharma
Thu, 04/13/17 - 06:49 pm
Novartis
Gilenya
MS
multiple sclerosis
generics
BMS and Pfizer file 16 Eliquis patent lawsuits to waylay generic makers
Fierce Pharma
Thu, 04/13/17 - 11:51 am
Bristol-Myers Squibb
Pfizer
patents
Eliquis
patent lawsuits
generics
bloodthinners
4 Reasons Why Roche Will Have the Best Growth in Big Pharma... and 1 Reason Why It Won't
Motley Fool
Wed, 04/12/17 - 10:33 am
Roche
Tecentriq
Perjeta
HER-2 postive breast cancer
Ocrevus
MS
multiple sclerosis
diagnostics
generics
biosimilars
Generics maker Akorn jumps on Fresenius takeout talks
BioPharma Dive
Tue, 04/11/17 - 10:02 am
generics
Akorn
Fresenius
M&A
GlaxoSmithKline Dodges a Bullet... for Now
Motley Fool
Sat, 04/8/17 - 01:06 pm
GSK
generics
Advair
asthma
Mylan Labs
Jazz Pharmaceuticals stock surges 7% on settlement with Hikma over generic drug
Marketwatch
Thu, 04/6/17 - 09:36 am
Jazz Pharmaceuticals
Hikma
generics
Xyrem
narcolepsy
GSK breathes sigh of relief as Mylan Advair copy rejected
BioPharma Dive
Wed, 03/29/17 - 10:37 pm
GSK
Advair
generics
Mylan Labs
Mylan stock sinks 2% after FDA fails to approve its generic asthma medication
Marketwatch
Wed, 03/29/17 - 04:56 pm
Mylan Labs
FDA
generics
asthma
GSK
Advair Diskus

Pages